Trademarkia Logo

Australia

AU$
ZUNISLA
Accepted: In opposition period

Last updated on 10 Sept 2024

Owner Info

Vertex Pharmaceuticals Incorporated

50 Northern Avenue

Boston MA 02210, UNITED STATES OF AMERICA

Serial Number

2461739 filed on 19 Dec 2023

Correspondent

Kelli A. Ovies Womble Bond Dickinson (US) LLP

555 Fayetteville Street, Suite 1100,

Raleigh NC 27601,

UNITED STATES OF AMERICA

ZUNISLA

Classification Information


Class [005]
Pharmaceutical preparations for treating diabetes; medical treatments in the nature of anti-diabetic pharmaceuticals; stem cell-derived cell therapy c Read More

Mark Details


Serial Number

2461739

Registered On

NA

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

11 Jul 2023

Mark Type

US

Legal History


Show more

Status DateAction Taken
10th Sept 2024International Registration in Australia Protected correspondence sent
9th Sept 2024IP Right Registration Published
9th Sept 2024Status change to Registered/Protected
3rd Jul 2024Application Accepted correspondence sent
2th Jul 2024IP Right has been Examined
2th Jul 2024IP Right Acceptance Published
2th Jul 2024Status change to Accepted
1st Jul 2024Awaiting examination
1st Jul 2024Examination expedited
27th Jun 2024IP Right Filed Published